1. Approval of Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March, 2026. 2. Recommendation of Final Dividend of Rs. 4.50/- per ....
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jeena Sikho Lifecare Limited reported strong FY2025-26 results with standalone revenue from operations growing 71% to Rs. 80,134.64 lakhs from Rs. 46,907.19 lakhs in FY25. Profit after tax nearly tripled to Rs. 22,217.57 lakhs from Rs. 7,994.33 lakhs, representing a 178% increase. The Board approved an unmodified (clean) audit opinion from Walker Chandiok & Co LLP for both standalone and consolidated results. The company recommended a final dividend of Rs. 4.50 per equity share (face value Rs. 2/-) for shareholder approval at the ensuing AGM. EBITDA margin expanded significantly from approximately 31% in FY25 to around 44% in FY26, indicating improved operational efficiency.
The company delivered exceptional growth with revenue and PAT both growing at rates well above industry averages. The clean audit opinion and dividend recommendation signal financial health, which could be positive for investor sentiment. The strong margin expansion demonstrates improved profitability and operational leverage.